首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1786975

帕金森氏症血液为基础的生物标记的全球市场，规模，占有率，产业分析报告:各生物标记类型，各用途，各技术平台，各终端用户，各地区 - 市场预测(2025年～2034年)

Blood-Based Biomarker for Parkinson's Disease Market Size, Share, Industry Analysis Report By Biomarker Type, By Application, By Technology Platform, By End User, By Region - Market Forecast, 2025-2034

出版日期: 2025年07月01日 | 出版商:

Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

根据 Polaris Market Research 的最新研究，预计到 2034 年，全球帕金森氏症血液生物标记市场规模将达到 27.1191 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

帕金森氏症血液生物标记是可在血液中检测到的分子指标，可用于了解疾病的存在、进展和治疗反应。随着医疗保健系统将重点从对症治疗转向及时干预和预防，并更加重视早期检测，这些生物标记正日益受到关注。对微创诊断方法日益增长的需求，促使临床研究人员和诊断开发人员开发能够在早期识别帕金森氏症的血液检测方法。这一趋势也得到了临床医生日益认识到生物标记在区分帕金森氏症与类似神经退化性疾病方面的效用的支持。

帕金森氏症血液生物标记市场正受到多组学技术整合的影响，旨在增强生物标记的发现和验证。基因组学、蛋白质组学和代谢组学的进展使我们能够在分子层面上更全面地了解帕金森氏症，从而能够鑑定出特异性和敏感性更高的新型血液生物标记。这些技术与临床研究的融合加快了生物标记的开发速度，并扩大了其在临床试验和个人化医疗中的应用。因此，市场正快速朝向精准驱动、数据驱动的诊断解决方案发展。

帕金森氏症血液生物标记市场亮点

按应用划分，诊断生物标记领域预计将在2024年以2.041亿美元的收入引领市场。

按生物标记类型划分，NFL生物标记领域预计在预测期内将录得最高的复合年增长率，达到19.00%，这得益于其作为多种神经系统疾病中神经退化性疾病的敏感指标的成熟应用。

得益于先进的医疗体係以及主要生物标记开发商和研究机构的集中分布，预计北美将在2024年占全球市场占有率的45.00%。

受生物医学研究投资、诊断服务增强以及疾病宣传活动不断加强的推动，预计亚太市场在 2025 年至 2034 年期间的复合年增长率将达到 20.50%。

帕金森氏症血液生物标记市场的全球领先公司包括雅培实验室、Adx Neurosciences、Alamar Biosciences、betaSENSE、罗氏公司、默克集团、Proteome Sciences、凯杰公司、Quanterix Corporation 和赛默飞世尔科技公司。

市场概述
帕金森氏症血液为基础的生物标记市场力学
- 促进因素和机会
  - 巴金森病患病率不断上升
  - 生物标记发现与验证的进展
- 限制因素与挑战
  - 缺乏标准化和临床验证
PESTEL分析
帕金森氏症血液为基础的生物标记市场趋势
价值链分析

第5章帕金森氏症血液为基础的生物标记的全球市场:各生物厂商类型

主要调查结果
简介
α-突触核蛋白(α-Syn)
神经长丝轻锁链(NfL)
发炎标记
代谢生物标记
其他

第6章帕金森氏症血液为基础的生物标记的全球市场:各用途

主要调查结果
简介
诊断生物标记
预后生物标记
生物标记的监测
治疗反应生物标记
其他

第7章帕金森氏症血液为基础的生物标记的全球市场:各技术平台

主要调查结果
简介
α-突触核蛋白种子扩增试验 (aSyn-SAA)
基于 ELISA 的试验
免疫试验
质谱光谱法
其他

第8章帕金森氏症血液为基础的生物标记的全球市场:各终端用户

主要调查结果
简介
医院和诊疗所
诊断检验室
研究机关
製药公司

第9章帕金森氏症血液为基础的生物标记的全球市场:各地区

主要调查结果
简介
- 帕金森氏症血液为基础的生物标记市场评估:各地区，2020年～2034年
北美
- 北美:各生物厂商类型，2020～2034年
- 北美:各用途，2020～2034年
- 北美:各技术平台，2020～2034年
- 北美:各终端用户，2020～2034年
- 美国
- 加拿大
欧洲
- 欧洲:各生物厂商类型，2020～2034年
- 欧洲:各用途，2020～2034年
- 欧洲:各技术平台，2020～2034年
- 欧洲:各终端用户，2020～2034年
- 英国
- 法国
- 德国
- 义大利
- 西班牙
- 荷兰
- 俄罗斯
- 其他欧洲
亚太地区
- 亚太地区:各生物厂商类型，2020～2034年
- 亚太地区:各用途，2020～2034年
- 亚太地区:各技术平台，2020～2034年
- 亚太地区:各终端用户，2020～2034年
- 中国
- 印度
- 马来西亚
- 日本
- 印尼
- 韩国
- 澳洲
- 其他亚太地区
中东·非洲
- 中东·非洲:各生物厂商类型，2020～2034年
- 中东·非洲:各用途，2020～2034年
- 中东·非洲:各技术平台，2020～2034年
- 中东·非洲:各终端用户，2020～2034年
- 沙乌地阿拉伯
- 阿拉伯联合大公国
- 以色列
- 南非
- 其他中东·aafurika
南美
- 南美:各生物厂商类型，2020～2034年
- 南美:各用途，2020～2034年
- 南美:各技术平台，2020～2034年
- 南美:各终端用户，2020～2034年
- 墨西哥
- 巴西
- 阿根廷
- 其他南美国家

第10章竞争情形

事业扩大·收购分析
- 事业扩大
- 收购
联盟/合作/协定/公开

第11章企业简介

Abbott Laboratories
Adx Neurosciences
Alamar Biosciences
betaSENSE
F. Hoffmann-La Roche Ltd
Merck KGaA
Merck KGaA
QIAGEN N.V.
Quanterix Corporation
Thermo Fisher Scientific Inc.

简介目录图表

Product Code: PM5992

The blood-based biomarker for Parkinson's disease market size is expected to reach USD 2,711.91 million by 2034, according to a new study by Polaris Market Research. The report "Blood-Based Biomarker for Parkinson's Disease Market Share, Size, Trends, Industry Analysis Report By Biomarker Type [Alpha-Synuclein (a-syn), Neurofilament Light Chain (Nfl)], By Application, By Technology Platform, By End User, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Blood-based biomarkers for Parkinson's disease are molecular indicators detectable in blood that provide insights into the presence, progression, and therapeutic response of the disease. These biomarkers are gaining prominence as healthcare systems focus on early-stage detection, aiming to shift from symptomatic treatment to timely intervention and prevention. The growing demand for minimally invasive diagnostic approaches is encouraging clinical researchers and diagnostic developers to advance blood-based assays capable of identifying Parkinson's at its earliest stages. This trend is also being supported by rising awareness among clinicians regarding the utility of biomarkers in differentiating Parkinson's from similar neurodegenerative disorders.

The blood-based biomarker for Parkinson's disease market is shaped by the integration of multi-omics technologies to enhance biomarker discovery and validation. Advances in genomics, proteomics, and metabolomics are enabling a more comprehensive understanding of Parkinson's disease at the molecular level, leading to the identification of novel blood-based biomarkers with improved specificity and sensitivity. This convergence of technology and clinical research is accelerating the pace of biomarker development and also expanding their applicability in clinical trials and personalized medicine. As a result, the market is evolving rapidly toward precision-driven, data-enabled diagnostic solutions.

Blood-Based Biomarker for Parkinson's Disease Market Report Highlights

In terms of application, the diagnostic biomarkers segment led revenue generation with USD 204.10 million in 2024, due to their critical role in detecting Parkinson's during early/prodromal stages when intervention is most impactful.

Based on biomarker type, the NfL biomarker segment is projected to register the highest CAGR of 19.00% during the forecast period, owing to its established utility as a sensitive neurodegeneration indicator across multiple neurological disorders.

North America held a 45.00% global share in 2024, benefiting from its advanced healthcare systems and the concentrated presence of leading biomarker developers and research institutions.

The market in Asia Pacific is expected to register a CAGR of 20.50% from 2025 to 2034, driven by investments in biomedical research, enhancements in diagnostic services, and rising awareness campaigns for diseases.

A few global key players in the blood-based biomarker for Parkinson's disease market include Abbott Laboratories, Adx Neurosciences, Alamar Biosciences, betaSENSE, F. Hoffmann-La Roche Ltd, Merck KGaA, Proteome Sciences, QIAGEN N.V., Quanterix Corporation, and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the blood-based biomarker for Parkinson's disease market report on the basis of biomarker type, application, technology platform, end user, and region:

By Biomarker Type Outlook (Revenue, USD Million, 2020-2034)

Alpha-Synuclein (a-Syn)

Neurofilament Light Chain (NfL)

Inflammatory Markers

Metabolic Biomarkers

Others

By Application Outlook (Revenue, USD Million, 2020-2034)

Diagnostic Biomarkers

Prognostic Biomarkers

Monitoring Biomarkers

Therapeutic Response Biomarkers

Others

By Technology Platform Outlook (Revenue, USD Million, 2020-2034)

Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA)

ELISA-Based Assays

Immunoassays

Mass Spectrometry

Others

By End User Outlook (Revenue, USD Million, 2020-2034)

Hospitals and Clinics

Diagnostic Laboratories

Research Institutes

Pharmaceutical Companies

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Blood-Based Biomarker for Parkinson's Disease Market Insights

4.1. Blood-Based Biomarker for Parkinson's Disease Market - Market Snapshot
4.2. Blood-Based Biomarker for Parkinson's Disease Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Parkinson's Disease
  - 4.2.1.2. Advancements in Biomarker Discovery and Validation
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of Standardization and Clinical Validation
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Blood-Based Biomarker for Parkinson's Disease Market Trends
4.6. Value Chain Analysis

5. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
5.3. Alpha-Synuclein (a-Syn)
- 5.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Alpha-Synuclein (a-Syn), by Region, 2020-2034 (USD Billion)
5.4. Neurofilament Light Chain (NfL)
- 5.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Neurofilament Light Chain (NfL), by Region, 2020-2034 (USD Billion)
5.5. Inflammatory Markers
- 5.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Inflammatory Markers, by Region, 2020-2034 (USD Billion)
5.6. Metabolic Biomarkers
- 5.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Metabolic Biomarkers, by Region, 2020-2034 (USD Billion)
5.7. Others
- 5.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
6.3. Diagnostic Biomarkers
- 6.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Diagnostic Biomarkers, by Region, 2020-2034 (USD Billion)
6.4. Prognostic Biomarkers
- 6.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Prognostic Biomarkers, by Region, 2020-2034 (USD Billion)
6.5. Monitoring Biomarkers
- 6.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Monitoring Biomarkers, by Region, 2020-2034 (USD Billion)
6.6. Therapeutic Response Biomarkers
- 6.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Therapeutic Response Biomarkers, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
7.3. Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA)
- 7.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Alpha-Synuclein Seeding Amplification Assay (aSyn-SAA), by Region, 2020-2034 (USD Billion)
7.4. ELISA-Based Assays
- 7.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by ELISA-Based Assays, by Region, 2020-2034 (USD Billion)
7.5. Immunoassays
- 7.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Immunoassays, by Region, 2020-2034 (USD Billion)
7.6. Mass Spectrometry
- 7.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
7.7. Others
- 7.7.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
8.3. Hospitals and Clinics
- 8.3.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Hospitals and Clinics, by Region, 2020-2034 (USD Billion)
8.4. Diagnostic Laboratories
- 8.4.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
8.5. Research Institutes
- 8.5.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Research Institutes, by Region, 2020-2034 (USD Billion)
8.6. Pharmaceutical Companies
- 8.6.1. Global Blood-Based Biomarker for Parkinson's Disease Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)

9. Global Blood-Based Biomarker for Parkinson's Disease Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Blood-Based Biomarker for Parkinson's Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Blood-Based Biomarker for Parkinson's Disease Market - North America
- 9.3.1. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.3.3. North America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.3.4. North America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. Blood-Based Biomarker for Parkinson's Disease Market - US
  - 9.3.5.1. US: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. Blood-Based Biomarker for Parkinson's Disease Market - Canada
  - 9.3.6.1. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.4. Blood-Based Biomarker for Parkinson's Disease Market - Europe
- 9.4.1. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.4.3. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.4.4. Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. Blood-Based Biomarker for Parkinson's Disease Market - UK
  - 9.4.5.1. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. Blood-Based Biomarker for Parkinson's Disease Market - France
  - 9.4.6.1. France: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. Blood-Based Biomarker for Parkinson's Disease Market - Germany
  - 9.4.7.1. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. Blood-Based Biomarker for Parkinson's Disease Market - Italy
  - 9.4.8.1. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. Blood-Based Biomarker for Parkinson's Disease Market - Spain
  - 9.4.9.1. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. Blood-Based Biomarker for Parkinson's Disease Market - Netherlands
  - 9.4.10.1. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. Blood-Based Biomarker for Parkinson's Disease Market - Russia
  - 9.4.11.1. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.5. Blood-Based Biomarker for Parkinson's Disease Market - Asia Pacific
- 9.5.1. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. Blood-Based Biomarker for Parkinson's Disease Market - China
  - 9.5.5.1. China: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. Blood-Based Biomarker for Parkinson's Disease Market - India
  - 9.5.6.1. India: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. Blood-Based Biomarker for Parkinson's Disease Market - Malaysia
  - 9.5.7.1. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. Blood-Based Biomarker for Parkinson's Disease Market - Japan
  - 9.5.8.1. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. Blood-Based Biomarker for Parkinson's Disease Market - Indonesia
  - 9.5.9.1. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. Blood-Based Biomarker for Parkinson's Disease Market - South Korea
  - 9.5.10.1. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. Blood-Based Biomarker for Parkinson's Disease Market - Australia
  - 9.5.11.1. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.6. Blood-Based Biomarker for Parkinson's Disease Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. Blood-Based Biomarker for Parkinson's Disease Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. Blood-Based Biomarker for Parkinson's Disease Market - UAE
  - 9.6.6.1. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. Blood-Based Biomarker for Parkinson's Disease Market - Israel
  - 9.6.7.1. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. Blood-Based Biomarker for Parkinson's Disease Market - South Africa
  - 9.6.8.1. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
9.7. Blood-Based Biomarker for Parkinson's Disease Market - Latin America
- 9.7.1. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. Blood-Based Biomarker for Parkinson's Disease Market - Mexico
  - 9.7.5.1. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. Blood-Based Biomarker for Parkinson's Disease Market - Brazil
  - 9.7.6.1. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. Blood-Based Biomarker for Parkinson's Disease Market - Argentina
  - 9.7.7.1. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. Blood-Based Biomarker for Parkinson's Disease Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Adx Neurosciences
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Alamar Biosciences
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. betaSENSE
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. F. Hoffmann-La Roche Ltd
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Merck KGaA
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. QIAGEN N.V.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Quanterix Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Thermo Fisher Scientific Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development

简介目录图表

List of Tables:

Table 1 Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 2 Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 3 Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 4 Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 5 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 6 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 7 North America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 8 North America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 9 US: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 10 US: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 11 US: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 12 US: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 13 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 14 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 15 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 16 Canada: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 17 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 18 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 19 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 20 Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 21 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 22 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 23 UK: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 24 UK: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 25 France: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 26 France: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 27 France: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 28 France: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 29 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 30 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 31 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 32 Germany: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 33 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 34 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 35 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 36 Italy: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 37 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 38 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 39 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 40 Spain: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 41 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 42 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 43 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 44 Netherlands: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 45 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 46 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 47 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 48 Russia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 49 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 50 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 51 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 52 Rest of Europe: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 53 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 54 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 55 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 56 Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 57 China: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 58 China: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 59 China: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 60 China: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 61 India: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 62 India: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 63 India: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 64 India: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 65 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 66 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 67 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 68 Malaysia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 69 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 70 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 71 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 72 Japan: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 73 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 74 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 75 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 76 Indonesia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 77 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 78 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 79 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 80 South Korea: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 81 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 82 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 83 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 84 Australia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 85 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 86 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 87 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 88 Rest of Asia Pacific: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 89 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 90 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 91 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 92 Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 93 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 94 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 95 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 96 Saudi Arabia: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 97 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 98 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 99 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 100 UAE: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 101 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 102 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 103 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 104 Israel: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 105 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 106 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 107 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 108 South Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 109 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 110 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 111 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 112 Rest of Middle East & Africa: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 113 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 114 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 115 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 116 Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 117 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 118 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 119 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 120 Mexico: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 121 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 122 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 123 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 124 Brazil: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 125 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 126 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 127 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 128 Argentina: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)
Table 129 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2020-2034 (USD Billion)
Table 130 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2020-2034 (USD Billion)
Table 131 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2020-2034 (USD Billion)
Table 132 Rest of Latin America: Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Blood-Based Biomarker for Parkinson's Disease Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Biomaker Type
Figure 7. Global Blood-Based Biomarker for Parkinson's Disease Market, by Biomaker Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Application
Figure 9. Global Blood-Based Biomarker for Parkinson's Disease Market, by Application, 2024 & 2034 (USD Billion)
Figure 10. Market by Technology Platform
Figure 11. Global Blood-Based Biomarker for Parkinson's Disease Market, by Technology Platform, 2024 & 2034 (USD Billion)
Figure 12. Market by End User
Figure 13. Global Blood-Based Biomarker for Parkinson's Disease Market, by End User, 2024 & 2034 (USD Billion)
Figure 14. Global Blood-Based Biomarker for Parkinson's Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
Figure 15. Strategic Analysis - Global Blood-Based Biomarker for Parkinson's Disease Market

02-2729-4219

+886-2-2729-4219

License/价格

帕金森氏症血液为基础的生物标记的全球市场，规模，占有率，产业分析报告:各生物标记类型，各用途，各技术平台，各终端用户，各地区 - 市场预测(2025年～2034年)